|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 564.00 GBX | +14.77% |
|
+13.34% | +50.48% |
| 06-08 | UK Shares Little Changed Amid Geopolitical Movements; Tate & Lyle Accepts Takeover Bid | MT |
| 06-08 | Stocks mixed amid lack of Middle East progress | AN |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.38B | 1.75B | 1.65B | 1.74B | 2.01B | |||||
Total Revenues | 1.38B | 1.75B | 1.65B | 1.74B | 2.01B | |||||
Cost of Goods Sold, Total | 696M | 876M | 796M | 825M | 1.09B | |||||
Gross Profit | 679M | 875M | 851M | 911M | 919M | |||||
Selling General & Admin Expenses, Total | 263M | 287M | 265M | 321M | 386M | |||||
Provision for Bad Debts | - | - | - | - | - | |||||
R&D Expenses | - | - | - | - | - | |||||
Depreciation & Amortization - (IS) | 56M | 59M | 58M | 86M | 124M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 24M | 36M | 36M | 42M | 48M | |||||
Other Operating Expenses | 173M | 270M | 261M | 211M | 120M | |||||
Other Operating Expenses, Total | 516M | 652M | 620M | 660M | 678M | |||||
Operating Income | 163M | 223M | 231M | 251M | 241M | |||||
Interest Expense, Total | -23M | -29M | -22M | -35M | -53M | |||||
Interest And Investment Income | 1M | 12M | 19M | 20M | 8M | |||||
Net Interest Expenses | -22M | -17M | -3M | -15M | -45M | |||||
Income (Loss) On Equity Invest. | - | -24M | 25M | - | - | |||||
Currency Exchange Gains (Loss) | -2M | -1M | - | -1M | -1M | |||||
Other Non Operating Income (Expenses) | - | - | - | -14M | -20M | |||||
EBT, Excl. Unusual Items | 139M | 181M | 253M | 221M | 175M | |||||
Restructuring Charges | -1M | -5M | -21M | -72M | 14M | |||||
Merger & Related Restructuring Charges | - | - | -2M | -80M | -35M | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Asset Writedown | -17M | -1M | -1M | - | - | |||||
Insurance Settlements | - | - | - | - | - | |||||
Legal Settlements | - | 3M | - | - | -5M | |||||
Other Unusual Items | -79M | -26M | -3M | 19M | -18M | |||||
EBT, Incl. Unusual Items | 42M | 152M | 226M | 88M | 131M | |||||
Income Tax Expense | 16M | 25M | 47M | 43M | 33M | |||||
Earnings From Continuing Operations | 26M | 127M | 179M | 45M | 98M | |||||
Earnings Of Discontinued Operations | 210M | 63M | 9M | 95M | - | |||||
Net Income to Company | 236M | 190M | 188M | 140M | 98M | |||||
Minority Interest | - | - | - | 3M | -1M | |||||
Net Income - (IS) | 236M | 190M | 188M | 143M | 97M | |||||
Net Income to Common Incl Extra Items | 236M | 190M | 188M | 143M | 97M | |||||
Net Income to Common Excl. Extra Items | 26M | 127M | 179M | 48M | 97M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.59 | 0.47 | 0.47 | 0.35 | 0.22 | |||||
Basic EPS - Continuing Operations | 0.07 | 0.31 | 0.45 | 0.12 | 0.22 | |||||
Basic Weighted Average Shares Outstanding | 399M | 404M | 397M | 409M | 442M | |||||
Net EPS - Diluted | 0.59 | 0.46 | 0.47 | 0.34 | 0.22 | |||||
Diluted EPS - Continuing Operations | 0.06 | 0.31 | 0.44 | 0.12 | 0.22 | |||||
Diluted Weighted Average Shares Outstanding | 403M | 411M | 404M | 415M | 447M | |||||
Normalized Basic EPS | 0.22 | 0.28 | 0.4 | 0.34 | 0.25 | |||||
Normalized Diluted EPS | 0.22 | 0.27 | 0.39 | 0.34 | 0.24 | |||||
Dividend Per Share | 0.22 | 0.18 | 0.19 | 0.2 | 0.2 | |||||
Payout Ratio | 61.02 | 38.42 | 40.43 | 55.94 | 90.72 | |||||
American Depositary Receipts Ratio (ADR) | 4 | 4 | 4 | 4 | 4 | |||||
Supplemental Items | ||||||||||
EBITDA | 250M | 296M | 303M | 356M | 392M | |||||
EBITA | 189M | 246M | 254M | 280M | 279M | |||||
EBIT | 163M | 223M | 231M | 251M | 241M | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 38.1 | 16.45 | 20.8 | 48.86 | 25.19 | |||||
Current Domestic Taxes | - | - | - | - | - | |||||
Current Foreign Taxes | - | - | - | - | - | |||||
Total Current Taxes | 36M | 45M | 71M | 36M | 50M | |||||
Total Deferred Taxes | -20M | -20M | -24M | 7M | -17M | |||||
Normalized Net Income | 86.88M | 113M | 158M | 141M | 108M | |||||
Interest on Long-Term Debt | 2M | 2M | 2M | 2M | 3M | |||||
Non-Cash Pension Expense | -8M | 5M | 3M | 5M | 9M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 41M | 46M | 44M | 50M | 62M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 12M | 20M | 13M | 12M | 8M | |||||
Total Stock-Based Compensation | 12M | 20M | 13M | 12M | 8M |
- Stock Market
- Stocks
- TATE Stock
- Financials Tate & Lyle plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















